Clinical trial
Olfactory Disfunction After COVID-19: Conventional Therapy Versus Intervention Treatment With Co-ultraPEALut
NCT04853836 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olfactory Disfunction After COVID-19: Conventional Therapy Versus Intervention Treatment With Co-ultraPEALut
- Lead sponsor
- University Of Perugia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 15, 2020
- Completion date
- August 31, 2022
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anosmia, covid19, hyposmia, parosmia, treatment compliance